APA (7th ed.) Citation

Hu, X., Li, D., Zhu, H., Yu, T., Xiong, X., & Xu, X. (2023). ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma. BMC.

Chicago Style (17th ed.) Citation

Hu, Xinyao, Dan Li, Hua Zhu, Tao Yu, Xiaoxing Xiong, and Ximing Xu. ATP6V1F Is a Novel Prognostic Biomarker and Potential Immunotherapy Target for Hepatocellular Carcinoma. BMC, 2023.

MLA (9th ed.) Citation

Hu, Xinyao, et al. ATP6V1F Is a Novel Prognostic Biomarker and Potential Immunotherapy Target for Hepatocellular Carcinoma. BMC, 2023.